المؤلفون: Kitadai R; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Japan., Zenke Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Hishima T; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Japan., Hosomi Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Japan.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Feb; Vol. 5 (2), pp. e1460. Date of Electronic Publication: 2021 May 27.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Brain Neoplasms/*secondary , Carcinoma, Non-Small-Cell Lung/*pathology , Lung Neoplasms/*pathology , Nivolumab/*administration & dosage, Aged ; Brain Neoplasms/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Female ; Humans ; Lung Neoplasms/drug therapy ; Magnetic Resonance Imaging ; Neoplasm Staging

المؤلفون: Gadde R; 2971Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA.; These authors contributed equally to the study., Arora K; 2971Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA.; These authors contributed equally to the study., Felicella MM; 115467Barrow Neurological Institute, Phoenix, AZ, USA., Arora S; Indiana University, Indianapolis, IN, USA., Cheng L; Indiana University, Indianapolis, IN, USA., Park H; 2971Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA., Gupta NS; 2971Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA., Salamat MS; 5229University of Wisconsin, Madison, WI, USA., Williamson SR; 2971Henry Ford Health System, Henry Ford Hospital, Detroit, MI, USA.; Wayne State University, Detroit, MI, USA.

المصدر: International journal of surgical pathology [Int J Surg Pathol] 2020 Dec; Vol. 28 (8), pp. 925-928. Date of Electronic Publication: 2020 Jun 04.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-2465 (Electronic) Linking ISSN: 10668969 NLM ISO Abbreviation: Int J Surg Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Brain Neoplasms/*therapy , Frontal Lobe/*pathology , Neoplasms, Germ Cell and Embryonal/*therapy , Trophoblastic Neoplasms/*diagnosis, Brain Neoplasms/blood ; Brain Neoplasms/diagnosis ; Brain Neoplasms/pathology ; Chemoradiotherapy, Adjuvant/methods ; Child ; Chorionic Gonadotropin, beta Subunit, Human/blood ; Chromosomes, Human, Pair 12/genetics ; Female ; Frontal Lobe/diagnostic imaging ; Frontal Lobe/drug effects ; Frontal Lobe/surgery ; Humans ; Magnetic Resonance Imaging ; Male ; Neoadjuvant Therapy ; Neoplasms, Germ Cell and Embryonal/blood ; Neoplasms, Germ Cell and Embryonal/diagnosis ; Neoplasms, Germ Cell and Embryonal/secondary ; Neurosurgical Procedures ; Proton Therapy ; Trophoblastic Neoplasms/secondary ; alpha-Fetoproteins/analysis

المؤلفون: Tosi F; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy., Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy., Lonardi S; Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy., Amatu A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Leone F; Department of Oncology, ASL BI, Ospedale degli Infermi, Biella, Italy; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy., Ghezzi S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Martino C; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy., Bencardino K; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bonazzina E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bergamo F; Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy., Fenocchio E; Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy., Martinelli E; Università della Campania 'L. Vanvitelli', Naples, Italy., Troiani T; Università della Campania 'L. Vanvitelli', Naples, Italy., Siravegna G; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy; Dipartimento di Oncologia, Università degli Studi di Torino, Turin, Italy., Mauri G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy., Torri V; Dipartimento di Oncologia, Istituto Mario Negri - IRCCS, Milan, Italy., Marrapese G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Valtorta E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cassingena A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cappello G; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy., Bonoldi E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Vanzulli A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Regge D; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy., Ciardiello F; Università della Campania 'L. Vanvitelli', Naples, Italy., Zagonel V; Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy., Bardelli A; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy; Dipartimento di Oncologia, Università degli Studi di Torino, Turin, Italy., Trusolino L; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy; Dipartimento di Oncologia, Università degli Studi di Torino, Turin, Italy., Marsoni S; Precision Oncology, IFOM-FIRC Institute of Molecular Oncology, Milan, Italy., Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy. Electronic address: salvatore.siena@unimi.it.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2020 Dec; Vol. 19 (4), pp. 256-262.e2. Date of Electronic Publication: 2020 Jun 27.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Brain Neoplasms/*drug therapy , Colorectal Neoplasms/*drug therapy , Lapatinib/*administration & dosage , Trastuzumab/*administration & dosage, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Brain/diagnostic imaging ; Brain/pathology ; Brain Neoplasms/diagnosis ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Lapatinib/adverse effects ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Progression-Free Survival ; Proto-Oncogene Proteins p21(ras)/genetics ; Receptor, ErbB-2/analysis ; Receptor, ErbB-2/metabolism ; Trastuzumab/adverse effects

المؤلفون: Leone JP; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Emblem KE; Department of Diagnostic Physics, Oslo University Hospital, Oslo, Norway., Weitz M; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Gelman RS; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Schneider BP; Indiana University School of Medicine, Indianapolis, IN, USA., Freedman RA; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Younger J; Massachusetts General Hospital, Boston, MA, USA., Pinho MC; University of Texas Southwestern Medical Center, Dallas, TX, USA., Sorensen AG; IMRIS Inc., Minnetonka, MN, USA., Gerstner ER; Massachusetts General Hospital, Boston, MA, USA., Harris G; Massachusetts General Hospital, Boston, MA, USA., Krop IE; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Morganstern D; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Sohl J; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Hu J; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Kasparian E; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Winer EP; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA., Lin NU; Dana-Farber Cancer Institute, Dana-Farber/Brigham & Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA. nlin@partners.org.

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 30; Vol. 22 (1), pp. 131. Date of Electronic Publication: 2020 Nov 30.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Bevacizumab/*administration & dosage , Brain Neoplasms/*drug therapy , Breast Neoplasms/*drug therapy , Carboplatin/*administration & dosage, Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/adverse effects ; Brain/diagnostic imaging ; Brain/pathology ; Brain Neoplasms/genetics ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Breast/pathology ; Breast Neoplasms/genetics ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Carboplatin/adverse effects ; Female ; Genotyping Techniques ; Humans ; Kaplan-Meier Estimate ; Magnetic Resonance Imaging ; Middle Aged ; Polymorphism, Single Nucleotide ; Progression-Free Survival ; Trastuzumab/administration & dosage ; Trastuzumab/adverse effects ; Vascular Endothelial Growth Factor A/genetics

المؤلفون: Li B; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China., Lv W; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Li C; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Yang J; Department of Clinical Nutrition, Beijing Children's Hospital, Capital Medical University, Beijing, China., Chen J; Centre of Endocrinology Genetics and Metabolism, National Centre for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China., Feng J; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Chen L; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Ma Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Li Y; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Wang J; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Liu Y; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Li Y; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Liu S; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Luo S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China., Qiu X; Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

المصدر: Cancer research and treatment [Cancer Res Treat] 2020 Oct; Vol. 52 (4), pp. 1050-1058. Date of Electronic Publication: 2020 Jul 09.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Brain Neoplasms/*therapy , Cranial Irradiation/*adverse effects , Craniospinal Irradiation/*adverse effects , Germinoma/*therapy , Neoplasm Recurrence, Local/*epidemiology, Adolescent ; Adult ; Brain Neoplasms/diagnosis ; Brain Neoplasms/mortality ; Chemoradiotherapy/methods ; Child ; Child, Preschool ; Cranial Irradiation/methods ; Craniospinal Irradiation/methods ; Disease-Free Survival ; Female ; Follow-Up Studies ; Germinoma/mortality ; Germinoma/pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/prevention & control ; Pineal Gland/diagnostic imaging ; Pineal Gland/radiation effects ; Quality of Life ; Radiotherapy Dosage ; Young Adult

المؤلفون: Helal A; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Helal.ahmed@Mayo.edu., Graffeo CS; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Perry A; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Cheville JC; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Link MJ; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA., Pollock BE; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: World neurosurgery [World Neurosurg] 2020 Jul; Vol. 139, pp. 12-19. Date of Electronic Publication: 2020 Apr 03.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101528275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-8769 (Electronic) Linking ISSN: 18788750 NLM ISO Abbreviation: World Neurosurg Subsets: MEDLINE

مواضيع طبية MeSH: Metastasectomy* , Radiosurgery*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*therapy , Lung Neoplasms/*therapy , Sarcoma/*therapy , Soft Tissue Neoplasms/*surgery , Toes/*surgery, Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Brain Neoplasms/secondary ; Female ; Femoral Neoplasms/diagnostic imaging ; Femoral Neoplasms/genetics ; Femoral Neoplasms/secondary ; Femoral Neoplasms/therapy ; Gene Rearrangement ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/secondary ; Magnetic Resonance Imaging ; Middle Aged ; Positron-Emission Tomography ; Repressor Proteins/genetics ; Sarcoma/diagnostic imaging ; Sarcoma/genetics ; Sarcoma/secondary ; Soft Tissue Neoplasms/genetics ; Soft Tissue Neoplasms/pathology ; Thoracic Surgery, Video-Assisted ; Tomography, X-Ray Computed

المؤلفون: Zhang J; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Xue W; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Xu K; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Yi L; Department of Neurosurgery, Daping Hospital, Army Medical University, Chongqing, 400042, China., Guo Y; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Xie T; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Tong H; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Zhou B; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Wang S; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Li Q; Department of Oncology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Liu H; Department of Radiology, PLA Rocket Force Characteristic Medical Center, Beijing, 100088, China., Chen X; Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, 400042, China., Fang J; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China., Zhang W; Department of Radiology, Daping Hospital, Army Medical University, Chongqing, 400042, China.; Chongqing Clinical Research Center of Imaging and Nuclear Medicine, Chongqing, 400042, China.

المصدر: Theranostics [Theranostics] 2020 Jun 05; Vol. 10 (16), pp. 7245-7259. Date of Electronic Publication: 2020 Jun 05 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy , Neovascularization, Pathologic/*diagnosis, Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Apoptosis/drug effects ; Bevacizumab/pharmacology ; Bevacizumab/therapeutic use ; Brain/blood supply ; Brain/diagnostic imaging ; Brain/drug effects ; Brain/pathology ; Brain Neoplasms/blood supply ; Brain Neoplasms/diagnosis ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Drug Synergism ; Glioblastoma/blood supply ; Glioblastoma/diagnosis ; Glioblastoma/pathology ; Human Umbilical Vein Endothelial Cells ; Humans ; Lactic Acid/analysis ; Lactic Acid/metabolism ; Male ; Mice ; Multiparametric Magnetic Resonance Imaging ; Neovascularization, Pathologic/drug therapy ; Neovascularization, Pathologic/pathology ; Phosphofructokinase-2/antagonists & inhibitors ; Phosphofructokinase-2/metabolism ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Vascular Endothelial Growth Factor A/metabolism ; Xenograft Model Antitumor Assays

المؤلفون: Gerstner ER; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts. egerstner@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts., Emblem KE; Department of Diagnostic Physics, Oslo University, Oslo, Norway., Chang K; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Vakulenko-Lagun B; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Yen YF; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Beers AL; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Dietrich J; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Plotkin SR; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Catana C; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Hooker JM; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Duda DG; Harvard Medical School, Boston, Massachusetts.; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Rosen B; Harvard Medical School, Boston, Massachusetts.; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Kalpathy-Cramer J; Harvard Medical School, Boston, Massachusetts.; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts., Jain RK; Harvard Medical School, Boston, Massachusetts.; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Batchelor T; Harvard Medical School, Boston, Massachusetts.; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 01; Vol. 26 (1), pp. 206-212. Date of Electronic Publication: 2019 Sep 26.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Capillary Permeability/*drug effects , Glioblastoma/*drug therapy , Neoplasm Recurrence, Local/*drug therapy, Adult ; Aged ; Bevacizumab/administration & dosage ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Chemotherapy, Cancer, Regional Perfusion ; Female ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Positron-Emission Tomography/methods ; Prognosis ; Temozolomide/administration & dosage

المؤلفون: Kebir S; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany. Sied.Kebir@uk-essen.de.; West German Cancer Center (WTZ), University Hospital Essen and German Cancer Consortium, Partner Site University Hospital Essen, University Duisburg-Essen, Essen, Germany. Sied.Kebir@uk-essen.de.; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Sied.Kebir@uk-essen.de., Schaub C; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Junold N; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Hattingen E; Institute of Neuroradiology, University of Frankfurt, Frankfurt, Germany., Schäfer N; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany., Weyerbrock A; Department of Neurosurgery, University of Freiburg, Freiburg, Germany., Hau P; Department of Neurology and Wilhelm Sander Neurooncology Unit, University of Regensburg, Regensburg, Germany., Goldbrunner R; Center for Neurosurgery, University of Cologne, Cologne, Germany., Galldiks N; Department of Neurology, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany., Weller J; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Mack F; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Tzaridis T; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Bähr O; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt, Germany., Seidel C; Department of Radiation Oncology, University of Leipzig, Leipzig, Germany., Schlegel U; Department of Neurology, Knappschaftskrankenhaus Klinikum Der Ruhr-Universität Bochum, Bochum, Germany., Schmidt-Graf F; Department of Neurology, Klinikum Rechts Der Isar, Technical University of Munich (TUM), Munich, Germany., Rohde V; Department of Neurosurgery, Georg-August-University, Göttingen, Germany., Borchers C; Department of Neurology, Nordwest-Krankenhaus Sanderbusch, Sande, Germany., Tabatabai G; Interdisciplinary Division of Neuro-Oncology, Departments of Neurology & Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübignen, Tübingen, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Chemnitz, Germany., Sabel M; Department of Neurosurgery, Medizinische Fakultät, Heinrich-Heine-Universität, Düsseldorf, Germany., Gerlach R; Department of Neurosurgery, HELIOS Klinikum Erfurt, Erfurt, Germany., Krex D; Department of Neurosurgery, Technical University Dresden, Dresden, Germany., Belka C; Department of Radiation Oncology, LMU Munich, Munich, Germany., Vatter H; Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany., Proescholdt M; Department of Neurosurgery, University of Regensburg, Regensburg, Germany., Glas M; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.; West German Cancer Center (WTZ), University Hospital Essen and German Cancer Consortium, Partner Site University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.

المصدر: Journal of neuro-oncology [J Neurooncol] 2019 Sep; Vol. 144 (3), pp. 501-509. Date of Electronic Publication: 2019 Jul 19.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*mortality , Glioblastoma/*mortality , Magnetic Resonance Imaging/*methods, Adult ; Aged ; Bevacizumab/administration & dosage ; Brain Neoplasms/drug therapy ; Brain Neoplasms/pathology ; Camptothecin/administration & dosage ; Dacarbazine/administration & dosage ; Female ; Follow-Up Studies ; Glioblastoma/drug therapy ; Glioblastoma/pathology ; Humans ; Irinotecan/administration & dosage ; Male ; Middle Aged ; Prognosis ; Survival Rate ; Temozolomide/administration & dosage

المؤلفون: Sahu KK; Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA., Pandey D; Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA., Mishra AK; Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA., O'Shea J; Division of Hematology and Medical Oncology, Saint Vincent Hospital, Worcester, Massachusetts, USA., Chen Y; Department of Pathology, Saint Vincent Hospital, Worcester, Massachusetts, USA., McGregor B; Department of Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

المصدر: BMJ case reports [BMJ Case Rep] 2019 Aug 26; Vol. 12 (8). Date of Electronic Publication: 2019 Aug 26.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/immunology , Adenocarcinoma*/pathology , Adenocarcinoma*/therapy , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Brain Neoplasms*/diagnostic imaging , Brain Neoplasms*/pathology , Brain Neoplasms*/secondary , Lymphatic Metastasis*/pathology , Lymphatic Metastasis*/therapy , Urinary Bladder Neoplasms*/immunology , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/therapy, Lymph Nodes/*pathology , Radiotherapy/*methods, Biopsy/methods ; Diagnosis, Differential ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Humans ; Immunohistochemistry ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Leucovorin/administration & dosage ; Leucovorin/adverse effects ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Neck ; Neoplasm Staging ; Organoplatinum Compounds/administration & dosage ; Organoplatinum Compounds/adverse effects

SCR Disease Name: Urachal cancer

SCR Protocol: Folfox protocol